Shri JB Pharma Private Ltd has submitted to the Exchange a copy of Disclosure pursuant to Regulations 31(1) and 31(2) of the SEBI ( SAST) Regulations, 2011.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shri JB Pharma Private Ltd has submitted a disclosure to the Exchange under Regulations 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The actual disclosure details — including any changes in shareholding, voting rights, or encumbrance data — are not contained in the document text available. Only digital signatures (by Govardhan Murlidhar Dhoot, dated August 12, 2025) are visible, with no supporting data on stake percentages, pledge details, or transaction type.
Since the underlying disclosure contents are not visible in this filing, there is no clear actionable signal for shareholders. Investors should look for the attached full disclosure document on the NSE/BSE portal to understand any change in promoter or acquirer shareholding of Mangalam Drugs and Organics.